Reply
Jesse Powell, Mandana Khalili – 18 October 2020
Lysyl Oxidase‐Like 4 Fosters an Immunosuppressive Microenvironment During Hepatocarcinogenesis
Hor‐Yue Tan, Ning Wang, Cheng Zhang, Yau‐Tuen Chan, Man‐Fung Yuen, Yibin Feng – 17 October 2020
Long‐Term Observation of Cyclosporine as Second‐Line Therapy in Adults for Severe Acute Autoimmune Hepatitis
Fumie Noguchi, Po‐sung Chu, Nobuhito Taniki, Aya Yoshida, Rei Morikawa, Akihiro Yamaguchi, Akihiko Ikura, Karin Yamataka, Hitomi Hoshi, Shingo Usui, Hirotoshi Ebinuma, Hidetsugu Saito, Takanori Kanai, Nobuhiro Nakamoto – 17 October 2020
Letter to the Editor: Recommendations for Implementing Hepatitis C Virus Care in Homeless Shelters: The Stakeholder Perspective
Brendan Harney, Roisin McColl, Alisa Pedrana, Eleanor Morrison, Joseph Doyle, Margaret Hellard, Peter Higgs – 16 October 2020
Liver Injury in Patients Hospitalized with Coronavirus Disease 2019 Correlates with Hyperinflammatory Response and Elevated Interleukin‐6
Ben L. Da, Tatyana Kushner, Maan El Halabi, Pavan Paka, Mian Khalid, Angad Uberoi, Brian T. Lee, Ponni V. Perumalswami, Stephanie M. Rutledge, Thomas D. Schiano, Scott L. Friedman, Behnam Saberi – 16 October 2020 – Liver injury is commonly seen in coronavirus disease 2019 (COVID‐19); however, the mechanism behind liver injury, particularly in patients with severe and critical COVID‐19, remains unclear, and the clinical course is poorly described.
LiverLearning®: Fundamentals of Liver Disease - Hepatitis B 2.0
DESCRIPTION There is currently an anticipated shortage of trained providers capable of diagnosing and treating different liver diseases. As a result of this increased demand and limited specialists in the field, more and more front-line providers are faced with these patients and do not have the experience or resources that will allow them to manage them appropriately.
Deficiency of Histone Methyltransferase SET Domain‐Containing 2 in Liver Leads to Abnormal Lipid Metabolism and HCC
Xue‐Jing Li, Qing‐Lan Li, Lin‐Gao Ju, Chen Zhao, Lan‐Shen Zhao, Jia‐Wen Du, Yan Wang, Ling Zheng, Bao‐Liang Song, Lian‐Yun Li, Li Li, Min Wu – 15 October 2020
LiverLearning®: 2020 Webinar: Treatment Strategies for Autoimmune Hepatitis Beyond First-line Therapy
Treatment failure. Incomplete response. Treatment intolerance. Management of autoimmune hepatitis can be extremely challenging when first-line therapy is inadequate. Join us for a discussion of alternative treatment options for autoimmune hepatitis and a review of their efficacy. Learn about updates to the treatment paradigm from the new 2019 guidelines!
Table of contents
14 October 2020
Instructions to Authors
14 October 2020